Gujarat Themis Biosyn Ltd

Tue 28/07/2026,15:41:53 | NSE : GUJTHEM

₹355.90-4.85 (-1.34%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 360.75

Previous Close

₹ 360.75

Volume

21278

Mkt Cap ( Rs. Cr)

₹3878.07

High

₹ 363.80

Low

₹ 355.00

52 Week High

₹ 479.00

52 Week Low

₹ 225.05

Book Value Per Share

₹ 26.41

Dividend Yield

0.18

Face Value

₹ 1.00

What’s Your Call?

Collective community sentiment on Gujarat Themis Biosyn Ltd

Your Vote -

Buy

88.24%

Hold

0.00%

Sell

11.76%

88.24%

17 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Gujarat Themis Biosyn Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Guj. Themis Bios - Copy of Newspaper Publication

    24 Jul 2026, 2:00PM Gujarat Themis Biosyn Limited has informed the Exchange about Copy of Newspaper Publication for Postal Ballot.

  • Guj. Themis Bios - Shareholders meeting

    23 Jul 2026, 11:07PM Gujarat Themis Biosyn Limited has informed the Exchange regarding Notice of Postal Ballot dated 22.07.2026

  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    23 Jul 2026, 10:59PM Please refer to the Notice of Postal Ballot 22.07.2026

  • Guj. Themis Bios - Revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with

    21 Jul 2026, 5:38PM The Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(

  • Guj. Themis Bios has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    21 Jul 2026, 7:00AM As of June 2026, 70.87% is owned by Indian Promoters and 29.14% by Public. <p align=justify> Top five Promoters holding highest number of shares of Gu

  • Guj. Themis Bios - Credit Rating- Revision

    20 Jul 2026, 7:27PM Gujarat Themis Biosyn Limited has informed the Exchange about Credit Rating- Revision

  • Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Credit Rating

    20 Jul 2026, 5:52PM Please refer to the attachment.

  • Guj. Themis Bios - Credit Rating- Revision

    17 Jul 2026, 5:24PM Gujarat Themis Biosyn Limited has informed the Exchange about Credit Rating- Revision

  • Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Credit Rating

    17 Jul 2026, 5:17PM Intimation of revision in credit rating

  • Guj. Themis Bios - Disclosure under SEBI Takeover Regulations

    15 Jul 2026, 11:35AM Sachin D. Patel has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial

  • Guj. Themis Bios - Disclosure under SEBI Takeover Regulations

    14 Jul 2026, 2:18PM PHARMACEUTICAL BUSINESS GROUP (INDIA) LIMITED has submitted toÿ the Exchange a copy ofÿDisclosure under Regulation 31 of the SEBI (Substantial Acquisi

  • Guj. Themis Bios - General Updates

    13 Jul 2026, 9:04PM Gujarat Themis Biosyn Limited has informed the Exchange about General Updates on Arbitration matter.

  • Guj. Themis Bios - Announcement Under Regulation 30 (LODR) - Updates On Arbitration Matter.

    13 Jul 2026, 8:58PM Please refer to our intimation under Regulation 30 (LODR) -Updates on Arbitration matter.

  • Guj. Themis Bios - Shareholders meeting

    10 Jul 2026, 4:59PM Gujarat Themis Biosyn Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot

  • Guj. Themis Bios - Shareholders meeting

    10 Jul 2026, 4:57PM Gujarat Themis Biosyn Limited has informed the Exchange regarding Proceedings of Postal Ballot. Further, the company has submitted the Exchange a copy

  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    10 Jul 2026, 4:56PM Please refer to the attachment.

  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    10 Jul 2026, 4:52PM Please refer to the attachment.

  • Guj. Themis Bios - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    10 Jul 2026, 3:40PM Gujarat Themis Biosyn Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Guj. Themis Bios - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    10 Jul 2026, 3:38PM Please refer to attached Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018.

  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    10 Jul 2026, 2:54PM Please refer to our Scrutinizer's Report and Voting Results of Postal Ballot dated 8th July, 2026.

  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    10 Jul 2026, 2:51PM Please refer to our Postal Ballot Outcome dated 8th July, 2026

  • Guj. Themis Bios - Shareholders meeting

    10 Jul 2026, 2:41PM Gujarat Themis Biosyn Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot

  • Guj. Themis Bios - Shareholders meeting

    10 Jul 2026, 2:35PM Gujarat Themis Biosyn Limited has informed the Exchange regarding Proceedings of Postal Ballot. Further, the company has submitted the Exchange a copy

  • Guj. Themis Bios - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulati

    4 Jul 2026, 11:27AM The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SE

  • Guj. Themis Bios - Disclosure under SEBI Takeover Regulations

    2 Jul 2026, 11:31AM Sachin D. Patel has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial

  • Guj. Themis Bios - Disclosure under SEBI Takeover Regulations

    1 Jul 2026, 11:15AM Sachin D. Patel has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made

  • Guj. Themis Bios - Investor Presentation

    29 Jun 2026, 8:32PM Gujarat Themis Biosyn Limited has informed the Exchange about Investor Presentation

  • Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Investor Presentation

    29 Jun 2026, 8:27PM Please refer to the attachment.

  • Guj. Themis Bios - Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

    26 Jun 2026, 7:53PM Gujarat Themis Biosyn Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

  • Guj. Themis Bios - Announcement Under Regulation 30 (LODR)-Updates

    26 Jun 2026, 7:48PM Please refer to the attachment.

  • Guj. Themis Bios - Trading Window

    25 Jun 2026, 6:14PM Gujarat Themis Biosyn Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulat

  • Guj. Themis Bios - Reply to Clarification- Financial results

    25 Jun 2026, 5:56PM The Exchange had sought clarification from Gujarat Themis Biosyn Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (

  • Guj. Themis Bios - Disclosure under SEBI Takeover Regulations

    24 Jun 2026, 12:00PM Sachin D. Patel has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial

  • Guj. Themis Bios - Clarification - Financial Results

    18 Jun 2026, 12:54PM The Exchange has sought clarification from Gujarat Themis Biosyn Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (

  • Guj. Themis Bios - Cancellation of Board Meeting

    17 Jun 2026, 9:18PM The Board Meeting to be held on 19/06/2026 Stands Cancelled.

  • Guj. Themis Bios - General Updates

    17 Jun 2026, 8:40PM Gujarat Themis Biosyn Limited has informed the Exchange about General Updates

  • Guj. Themis Bios - Announcement Under Regulation 30 - Updates

    17 Jun 2026, 8:35PM Please refer to the attachmnet

  • Guj. Themis Bios - Board Meeting Intimation for Inter Alia, To Evaluate Proposal For Raising Funds Through Issue Of Equity Sh

    16 Jun 2026, 9:21PM Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/06/2026 ,inter alia, to conside

  • Guj. Themis Bios - Copy of Newspaper Publication

    9 Jun 2026, 2:34PM Gujarat Themis Biosyn Limited has informed the Exchange about Copy of Newspaper Publication

  • Guj. Themis Bios - Shareholders meeting

    8 Jun 2026, 11:49PM Gujarat Themis Biosyn Limited has informed the Exchange regarding Notice of Postal Ballot

  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    8 Jun 2026, 11:45PM Please refer to the attachment.

  • Guj. Themis Bios - Outcome of Board Meeting

    6 Jun 2026, 7:22PM Gujarat Themis Biosyn Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 06, 2026.

  • Guj. Themis Bios - Board Meeting Outcome for Outcome Of The Board Meeting Held On 6Th June, 2026

    6 Jun 2026, 7:17PM Please refer to the attachment.

  • Guj. Themis Bios - Shareholders meeting

    5 Jun 2026, 12:21PM Gujarat Themis Biosyn Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange r

  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    5 Jun 2026, 12:10PM Voting Results on Postal Ballot through e-voting and Scrutinizer's Report dated 04th June, 2026.

  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    5 Jun 2026, 12:06PM Please refer to Voting Results and Scrutinizer's Report on Postal Ballot dated 4th June, 2026

  • Guj. Themis Bios - Board Meeting Intimation for Consideration And Evaluate The Proposals For Raising Funds By Way Of Issue Of

    3 Jun 2026, 6:13PM Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/06/2026 ,inter alia, to conside

  • Guj. Themis Bios - Announcement Under Regulation 30 - Updates (Incorporation Of Wholly Owned Subsidiary)

    29 May 2026, 11:03PM Please refer to the attachment.

  • Guj. Themis Bios - Copy of Newspaper Publication

    26 May 2026, 6:45PM Gujarat Themis Biosyn Limited has informed the Exchange about Copy of Newspaper Publication

  • Guj. Themis Bios - Investor Presentation

    25 May 2026, 3:46PM Gujarat Themis Biosyn Limited has informed the Exchange about Investor Presentation

  • Guj. Themis Bios - Outcome of Board Meeting

    25 May 2026, 3:14PM Gujarat Themis Biosyn Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

  • Guj. Themis Bios Q4 net profit down 9.25% at Rs 10.89 cr

    25 May 2026, 4:00PM The company reported standalone net profit of Rs 10.89 crore for the quarter ended March 31, 2026 as compared to Rs 12.00 crore in the same period las

  • Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Investor Presentation

    25 May 2026, 3:44PM Please refer to the attachment.

  • Guj. Themis Bios - Results - Audited Financial Results For The Quarter And Year Ended 31.03.2026

    25 May 2026, 3:27PM Please refer to the attachment

  • Guj. Themis Bios - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of The SEBI (Listing Obligations An

    25 May 2026, 3:07PM The Board of Directors at its meeting held today, have inter alia, transacted the following items of\r\nbusiness and taken the decisions as under:\r\n

  • Guj. Themis Bios - Investor Presentation

    22 May 2026, 8:51PM Gujarat Themis Biosyn Limited has informed the Exchange about Investor Presentation

  • Guj. Themis Bios - Press Release

    22 May 2026, 8:48PM Gujarat Themis Biosyn Limited has informed the Exchange regarding a press release dated May 22, 2026, titled ""Press Release dated 22nd May, 2026"".

  • Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Investor Presentation

    22 May 2026, 8:45PM Please refer to the attachment.

  • Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    22 May 2026, 8:43PM Please refer to the attachment.

  • Guj. Themis Bios - Agreements

    22 May 2026, 8:40PM Gujarat Themis Biosyn Limited has informed the Exchange about Agreements

  • Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Acquisition

    22 May 2026, 8:37PM Please refer to the attachment.

  • Guj. Themis Bios - Update on board meeting

    20 May 2026, 11:12PM Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to conside

  • Guj. Themis Bios - General Updates

    20 May 2026, 9:17PM Gujarat Themis Biosyn Limited has informed the Exchange about General Updates

  • Guj. Themis Bios - Announcement Under Regulation 30 (LODR) - Updates

    20 May 2026, 9:14PM Intimation under Regulation 30 of SEBI (LODR)

  • Guj. Themis Bios - General Updates

    19 May 2026, 7:46PM Gujarat Themis Biosyn Limited has informed the Exchange about General Updates

  • Guj. Themis Bios - Announcement Under Regulation 30 Of SEBI (LODR) - Updates

    19 May 2026, 7:22PM Please refer to our intimation under reg 30 of SEBI (LODR) Regulations, 2015 w.r.t. incorporation of wholly owned subsidiary in Japan.

  • Guj. Themis Bios - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended 31St Mar

    19 May 2026, 12:29PM Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to conside

  • Guj. Themis Bios - Copy of Newspaper Publication

    6 May 2026, 12:21PM Gujarat Themis Biosyn Limited has informed the Exchange about Copy of Newspaper Publication

  • Guj. Themis Bios - Shareholders meeting

    5 May 2026, 9:49PM Gujarat Themis Biosyn Limited has informed the Exchange regarding Notice of Postal Ballot

  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    5 May 2026, 9:37PM Notice of Postal Ballot dated 7th April, 2026.
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Gujarat Themis Biosyn Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 447.6232 278.2718 201.376 149.1459 103.3214
Liabilities 447.6232 278.2718 201.376 149.1459 103.3214
Equity 10.8965 10.8965 7.2644 7.2644 7.2644
Gross Profit 75.5301 68.8444 78.7337 74.2174 58.0452
Net Profit 46.6815 48.7717 59.1632 57.9688 43.6242
Cash From Operating Activities 48.7774 91.0286 64.213 39.5009 40.3132
NPM(%) 28.15 32.34 34.83 38.91 37.98
Revenue 165.8228 150.7999 169.8219 148.9729 114.8539
Expenses 90.2927 81.9555 91.0882 74.7555 56.8087
ROE(%) 16.22 16.94 20.56 20.14 15.16

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
0.67 67 0.19 389.35
04 Sep 2025 0.67 67 0.19 325.7

Peers

Other companies within the same industry or sector that are comparable to Gujarat Themis Biosyn Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 685.00 0.11 0.00 205.83 -26.19 0.73
Lotus Eye Hospital and Institute Ltd 118.57 -0.32 3952.33 750.02 0.39 0.00
Vaishali Pharma Ltd 7.39 -4.27 24.63 4705.12 15.42 0.00
Astec Lifesciences Ltd 649.45 -2.28 0.00 803.60 -363.14 0.00

Company Info

Gujarat Themis Biosyn Ltd. was incorporated in 1981 jointly by GIIC and chemosyn (P) Ltd. GIBL commenced production in Aug.1985 by producing antibiotic erythromycin, and erythromycin salts and formulations. GTBL was a sick company which was forced to discontinue production because of accumulated losses. The company was takenover during June 1991 by pharmaceutical Business Group India Ltd; a unique consortium of five competing drug companies - Themis Chemicals, Kopran, Anant & Co., Cadila and Lyka Labs. The company has technical and financial collaboration with Yuhan Corporation, South Korea. With Yuhan's knowhow, GTBL has become India's first company to start commercial production of anti-tubercolis drug, rifampicin. 2002-Gujarat Themis Biosyn Ltd has informed that Mr Rajneesh Anand has been appointed as the Managing Director of the Company w e f February 01, 2002. 2008 -Gujarat Themis Biosyn Ltd has appointed Mr. S S Lee as an Additional Director of the Company. -The Company has appointed Mr. Rajneesh Anand as Managing Director 2010 - Gujarat Themis Biosyn Ltd has appointed Mr. Subhash C Kaushik as Additional Director of the Company. 2011 -The Board of Directors appointed Mr. Rajneesh Anand as Managing Director of the Company 2012 -The Company has received a Rehabilitation Scheme approved by the Board of Industrial and Financial Reconstruction (BIFR) 2014 -Mr. Vikas Tarekar has been appointed as a Company Secretary of the company. -Mr. Tapas Guha has been appointed as a CEO of the Company. 2023 -The Company has splits its face value from Rs. 5/- to Rs. 1/-. 2024 -The Company has issued Bonus Shares in the Ratio of 1:2.-The Company has approved the Scheme of Amalgamation of Gujarat Themis Biosyn Ltd. with Themis Medicare Ltd.      2025-The Company has listed his 10,89,65,265 equity shares of face value of Rs.1/- each, fully paid up in National Stock Exchange (NSE)

Gujarat Themis Biosyn Ltd. was incorporated in 1981 jointly by GIIC and chemosyn (P) Ltd. GIBL commenced production in Aug.1985 by producing antibiotic erythromycin, and erythromycin salts and formulations. GTBL was a sick company which was forced to discontinue production because of accumulated losses. The company was takenover during June 1991 by pharmaceutical Business Group India Ltd; a unique consortium of five competing drug companies - Themis Chemicals, Kopran, Anant & Co., Cadila and Lyka Labs. The company has technical and financial collaboration with Yuhan Corporation, South Korea. With Yuhan's knowhow, GTBL has become India's first company to start commercial production of anti-tubercolis drug, rifampicin. 2002-Gujarat Themis Biosyn Ltd has informed that Mr Rajneesh Anand has been appointed as the Managing Director of the Company w e f February 01, 2002. 2008 -Gujarat Themis Biosyn Ltd has appointed Mr. S S Lee as an Additional Director of the Company. -The Company has appointed Mr. Rajneesh Anand as Managing Director 2010 - Gujarat Themis Biosyn Ltd has appointed Mr. Subhash C Kaushik as Additional Director of the Company. 2011 -The Board of Directors appointed Mr. Rajneesh Anand as Managing Director of the Company 2012 -The Company has received a Rehabilitation Scheme approved by the Board of Industrial and Financial Reconstruction (BIFR) 2014 -Mr. Vikas Tarekar has been appointed as a Company Secretary of the company. -Mr. Tapas Guha has been appointed as a CEO of the Company. 2023 -The Company has splits its face value from Rs. 5/- to Rs. 1/-. 2024 -The Company has issued Bonus Shares in the Ratio of 1:2.-The Company has approved the Scheme of Amalgamation of Gujarat Themis Biosyn Ltd. with Themis Medicare Ltd.      2025-The Company has listed his 10,89,65,265 equity shares of face value of Rs.1/- each, fully paid up in National Stock Exchange (NSE)

Parent Organisation

Gujarat Themis Biosyn Ltd.

Founded

11/12/1981

Managing Director

Dr.Sachin D Patel

NSE Symbol

GUJTHEMEQ

FAQ